NCT03023683View on ClinicalTrials.gov

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Influenza
Interventions
BIOLOGICAL

FluMist®

Influenza Virus Vaccine Live, Intranasal Spray

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT03023683 - Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024) | Biotech Hunter | Biotech Hunter